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Abstract
Background: Termination of protein synthesis in eukaryotes involves at least two polypeptide
release factors (eRFs) – eRF1 and eRF3. The highly conserved translation termination factor eRF1
in Saccharomyces cerevisiae is encoded by the essential gene SUP45.
Results:  We have isolated five sup45-n (n from nonsense) mutations that cause nonsense
substitutions in the following amino acid positions of eRF1: Y53 → UAA, E266 → UAA, L283 →
UAA, L317 → UGA, E385 → UAA. We found that full-length eRF1 protein is present in all mutants,
although in decreased amounts. All mutations are situated in a weak termination context. All these
sup45-n mutations are viable in different genetic backgrounds, however their viability increases
after growth in the absence of wild-type allele. Any of sup45-n mutations result in temperature
sensitivity (37°C). Most of the sup45-n mutations lead to decreased spore viability and spores
bearing  sup45-n  mutations are characterized by limited budding after germination leading to
formation of microcolonies of 4–20 cells.
Conclusions: Nonsense mutations in the essential gene SUP45 can be isolated in the absence of
tRNA nonsense suppressors.
Background
Termination of protein synthesis occurs when the ribos-
ome elongation machinery encounters an in-frame termi-
nation (stop) codon, either UAG, UGA or UAA, in the
mRNA. This stop codon located in the A-site of the ribos-
ome is recognized by a release factor (RF1/RF2 in prokary-
otes and eRF1 in eukaryotes), which triggers release of the
nascent peptide from the ribosome. Termination effi-
ciency is enhanced by the GTPase release factor, RF3 in
prokaryotes and eRF3 in eukaryotes [reviewed in [1-4]].
Release factor eRF1 recognizes all three stop codons [5], in
contrast to prokaryotes where RF1 catalyses translation
termination at UAG and UAA codons, and RF2 at UGA
and UAA codons [6]. All these proteins are encoded by
essential genes: prfA (for RF1), prfB (for RF2) in bacteria
[7-9] and SUP45  (for eRF1) in S. cerevisiae [10,11].
Although the sequences of prokaryotic and eukaryotic
release factors differ significantly [see [12] for review], a
"tRNA-mimicry" model generalizing the mechanisms of
prokaryotic and eukaryotic translation termination, was
proposed [13]. Peptide determinants of RF1 and RF2
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involved in the specificity of stop codon recognition have
been identified: in both cases a tripeptide (PAT for RF1
and SPF for RF2) was located in the homologous region of
both proteins [14].
Recently the crystal structures of human eRF1 and bacte-
rial RF2 have been determined and found to be different
[15,17]. However, when associated to the ribosome RF2,
conformation is modified and mimics a tRNA molecule
[16,18]. Thus both eRF1 and RF2 may have comparable
structures both of which are compatible with tRNA mim-
icry model as proposed previously [13]. The eRF1 is com-
posed of three domains. Domain 3 corresponds to the C-
terminal part of eRF1 that is necessary for the interaction
with eRF3 although there are some discrepancies in the
precise localization of the region of eRF1 that interacts
with eRF3 [19-22]. Domain 2 is responsible for the pepti-
dyl transferase hydrolytic activity and includes a GGQ
motif that has been highly conserved through evolution
[23]. Mutations of GGQ (Gly residues) are dominant-neg-
ative in vitro [23] and lethal in vivo in S. cerevisiae cells [15].
The function of domain 1 remains unknown although it
was proposed that together with domain 2, it could form
a functionally active "core" domain [24]. The role of N-
terminal domain of eRF1 in stop codon recognition has
been proposed [15] and supported by mutational
approach [25] and crosslinking experiments [26].
In eukaryotes eRF1 interacts with eRF3 in vivo [27,28].
This interaction is mediated by the C-terminus of eRF1
[20,21]. The deletion of the 19 C-terminal amino acids
abolishes the interaction with eRF3, causes an enhance-
ment of nonsense suppression, but does not destroy via-
bility. In contrast, eRF1 with a 32 C-terminal amino acid
deletion is unable to support viability [20]. Also it has
been shown that nonsense mutations (UAA) in the SUP45
gene lead to lethality in the absence of SUQ5 suppressor
[29]. However, a viable nonsense mutant has been iso-
lated for the prfB gene of S. typhimurium encoding RF2
release factor. It has been proposed that this mutation
reduces the cellular amount of RF2 leading to inefficient
termination of translation and autosuppression [30].
In the present work we have isolated five spontaneous
nonsense mutations in the SUP45 gene that confer viabil-
ity in different genetic backgrounds. These mutations
result in a decreased level of full-length eRF1, thermosen-
sitivity and lethality in meiotic segregation of hetero-
zygous diploids.
Results
Isolation of nonsense mutations in the SUP45 gene
After selection for histidine (his7-1 (UAA)) – lysine (lys9-
A21  (UAA)) prototrophy, sixteen SUP45  mutants and
eighty-four SUP35 mutants among 400 His+ Lys+ rever-
tants were obtained. All sup45  mutant alleles together
with the wild-type SUP45 allele from parent strain 1B-
D1606 were cloned using PCR. The DNA sequence for
each of the cloned alleles was determined.
The sequencing of the parent strain 1B-D1606 revealed 6
nucleotide substitutions compared with the published
sequence [10]: A69G, G519T, T687C, T702A, G927A,
T1008C. All of these, except T702, are the same as those
described earlier [10] for mutant alleles that obviously
had a different origin regarding the wild-type strain. All
nucleotide substitutions are localized in the third codon
position and do not change the amino acid residues. The
reason for these differences could be the origin of the
strain from Petergoff Breeding Stocks (XII race S. cerevi-
siae) that has an independent origin [31] compared to the
strains used in other laboratories [32].
Comparison of the mutant SUP45 DNA sequences with
that of the parent strain revealed that in all cases only a
single-base changed in the coding sequence. Surprisingly,
among 16 mutations 5 represented nonsense mutations,
resulting in the mutations of sense codon to an ochre
(TAA) (four mutations) or (TAG) nonsense codon (one
mutation) (Figure 1). The other 9 were missense muta-
tions and will be described elsewhere. Strains bearing
sup45-101, sup45-102, sup45-104, sup45-105, sup45-107
that contain, respectively, the following base substitu-
tions: G796T, T159A, T848A, G1153T and T950G, which
lead to nonsense mutations, were further characterized.
Nonsense mutations in the SUP45 gene lead to 
readthrough of the mutated stop codon
All the mutations were defined as omnipotent suppres-
sors after testing for histidine, lysine, adenine and tryp-
tophan auxotrophy; his7-1 (UAA), lys9-A21 (UAA,) ade1-
14 (UGA) and trp1-289 (UAG) mutation one present in
the parent strain (Figure 2A).
To determine the level of nonsense suppression in the dif-
ferent  SUP45  mutants a vector based assay system for
quantification of nonsense codon readthroughin vivo was
employed [33]. β-galactosidase activities measurements
in the mutants are consistent with the results obtained for
auxotrophy (Figure 2A): the parent strain does not possess
any suppressor activity. In the omnipotent mutants tested,
nonsense suppression levels of all stop codons were high
(between 8- and 28% for UAA; between 10- and 25% for
UAG, and between 22- and 42% for UGA) (Figure 2B).
Since the C-terminal region of eRF1 is essential for cell via-
bility [10,11], some full-length eRF1 should be present
even in strains bearing sup45 nonsense mutations (which
will be referred to as sup45-n, where n equals nonsense),
probably by readthrough of the stop codon. An affinity-BMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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purified anti-eRF1 antibody was used in the Western blot
analysis to examine eRF1 levels in SUP45  mutants. As
shown in Figure 2C, there was a considerable amount of
full-length eRF1 in sup45-n strains. Comparison with a
wild-type strain revealed a significant decrease in the
amount of eRF1 protein. Ribosome fractions isolated
from sup45-104, sup45-105, sup45-107 contained a trun-
cated protein with molecular mass consistent with the
predicted one (31.5, 43.0 and 35.2 kDa, respectively)
(Figure 2C).
Western blot analysis did not reveal the presence of trun-
cated protein either in ribosome fractions, or in lysates
prepared from sup45-101 strain (Figure 2C and data not
shown). The inability to detect such truncated protein
with a predicted molecular mass of 29.6 kDa could be
explained by its proteolytic sensitivity possibly because of
the absence of the ribosome-binding site. The small trun-
cated protein (5.9 kDa) in sup45-102 strain could not be
detected. Relative to the level of eRF1 in wild-type strain
1B-D1606 (set to 1), the amount of full-length eRF1 in
101-D1606, 102-D1606, 104-D1606, 105-D1606 and
107-D1606 strains were 0.32, 0.08, 0.13, 0.14 and 0.17,
respectively. The highest level of eRF1 in sup45-101 strain
Schematic representation of sup45-n mutations isolated in  present work Figure 1
Schematic representation of sup45-n mutations iso-
lated in present work. Position of the mutations is indi-
cated above the SUP45 gene. The numbers under the SUP45 
gene correspond to amino acid positions whose codons 
were changed to premature stop codons. Numbers on the 
right of arrows correspond to the size of truncated eRF1 
protein.
Nonsense mutations in the SUP45 gene lead to omnipotent  suppression Figure 2
Nonsense mutations in the SUP45 gene lead to 
omnipotent suppression. A. Plate assays showing the 
growth of yeast strains bearing nonsense mutations in the 
SUP45 gene (101-1B-D1606, 102-1B-D1606, 104-1B-D1606, 
105-1B-D1606, 107-1B-D1606) in the synthetic medium 
without histidine (SC-His), lysine (SC-Lys), adenine (SC-Ade) 
or tryptophan (SC-Trp) at 25°C compared with the parent 
strain 1B-D1606. The types of nonsense mutations in parent 
strain are denoted under media indications. SUP45 mutant 
alleles are indicated. Ten serial dilutions of yeast suspension 
of the same density were used. Five independent clones were 
tested, representative results are shown. B. Determination 
of the level of nonsense suppression in sup45-n mutants. 
UAA, UAG and UGA suppression levels were quantified by 
measuring β-galactosidase levels in the strains 1B-D1606 
(wild type) as control and in mutants transformed with plas-
mids pUKC817, pUKC818 or pUKC819 bearing a specific 
stop codon (TAA, TAG or TGA, respectively) in frame that 
precedes lacZ gene. The efficiency of nonsense codon 
readthrough (%) was quantified as a ratio of β-galactosidase 
activity in cells harboring lacZ with stop codon to that in cells 
without a stop codon in-frame with the lacZ gene in 
pUKC815 plasmids. The same strains as in Fig. 2A were used. 
Results are the means of three separate experiments. C. 
Western blot showing the synthesis of full-length eRF1 (49 
kDa) and truncated eRF1 proteins with predicted molecular 
mass 43.0 kDa, 35.2 kDa and 31.5 kDa for mutants 105, 107 
and 104, respectively. (*) Indicates a non-specific band. A 
search of yeast proteome with the N-terminal peptide 
sequence that was used for antibody production, revealed 
the presence of one protein (methionyl-tRNA synthetase, 
GenBank accession number CAA24627) containing this 
sequence that has an expected molecular weight near 85 
kDa. Cultures of the same strains as in (A) were grown to 
mid-log phase in medium selective for plasmid and ribosome 
fractions were prepared. The same amount of each sample 
was loaded per lane. Immunoblot analysis was performed 
using polyclonal antibodies directed against the N-terminal 
part of eRF1.BMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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corresponds to the lowest level of suppression as meas-
ured by β-galactosidase assay (Figure 2B). These results
suggest that a very small amount of eRF1 is required for
cell viability.
The effect of reducing eRF1 on cell viability was evaluated
next. All sup45-n mutations (but not all missense muta-
tions, data not shown) lead to temperature-sensitive
lethality (Figure 3). Previously, the analogous phenotype
caused by opal supK584 mutation in the RF2 gene of S.
typhimurium  was explained by a reduced level of the
mature RF2 protein at higher temperature [30]. To deter-
mine whether this was also the case for yeast strains carry-
ing sup45-n alleles, ribosomes were isolated from wild-
type strain 1B-D1606 or the 104-1B-D1606 strain after
two and four hours of incubation at 37°C. Western blot
analysis did not reveal the significant difference in the
amount of full-length eRF1 protein at the non-permissive
temperature as compared with the permissive tempera-
ture both in the mutant and in the wild-type strains (data
not shown).
Do sup45-n mutations lead to lethality in different genetic 
backgrounds?
The viability of strains bearing nonsense mutations in the
essential SUP45 gene may be explained in several ways. It
is possible that the parent strain itself contains weak tRNA
suppressor. However, the level of readthrough in this
strain, measured in a quantitative termination codon
readthrough assay, is negligible (Figure 2B).
To further examine this possibility plasmid shuffle analy-
sis was performed. The haploid yeast strain 1A-D1628 was
transformed with the pRS315 plasmids bearing different
sup45-n mutations. In this strain the lethal SUP45 disrup-
tion was complemented by the SUP45 gene on an URA3
centromeric plasmid, pRS316. Transformants were then
subjected to plasmid shuffle analysis [34] to verify
whether strains containing the sup45-n alleles could lose
the plasmid carrying the wild-type gene. Leu+ Ura+ trans-
formants were plated on 5-FOA medium to select against
[URA3 SUP45] plasmid. Control cells transformed with
[LEU2 SUP45] plasmid grew on 5-FOA. Cells transformed
with pRS315/sup45-n  plasmids also grew on 5-FOA
medium although with different efficiencies (Figure 4A).
Ura- Leu+ colonies were selected and tested for adenine
and tryptophan auxotrophy. In all cases sup45-n muta-
tions lead to suppression of ade1-14 and trp1-289 (Figure
4B). Again, the Western blot analysis showed that in all
SUP45::HIS3 [sup45-n] strains full-length eRF1 had been
synthesized to a lesser extent compared with SUP45::HIS3
[SUP45] strain (Figure 4C).
To further confirm that viability of sup45-n  mutations
could not be explained by the presence of weak tRNA sup-
pressor mutation in the parent strain plasmid, shuffle
analysis was performed on the derivative of S288C [35]
whose entire genomic sequence does not contain muta-
tions in tRNA genes [36]. A haploid strain 1A-Y23282
bearing SUP45 disruption and the [URA3 SUP45] plasmid
pRS316/SUP45  was transformed with [LEU2 sup45-n]
plasmids and the resulting transformants were plated on
5-FOA medium. All transformants were able to grow in
the presence of 5-FOA (Figure 4D).
The comparison of data presented in Figures 4A and 4D
shows that the efficiency of the plasmid shuffle varies sig-
nificantly among mutations being the least for sup45-105
and the highest for sup45-101. To compare the efficiency
of plasmid shuffle quantitatively the maintenance of plas-
mid with wild-type SUP45 was tested. The haploid yeast
strain 1A-D1628 carrying the SUP45 gene on centromeric
plasmid pRS315 was transformed with pRS316 plasmids
bearing different sup45-n  mutations. Cotransformants
were plated at 200 cells per Petri dish on YPD medium,
grown at 25°C for several days and replica plated on SC-
Ura and SC-Leu media. 200 to 500 colonies were tested
from 3 independent transformants. All cotransformants
were able to lose either [SUP45 LEU2] or [sup45-n URA3]
plasmid but with different efficiency. The plasmid pRS316
bearing mutant sup45-n alleles were lost in 15–20% of
tested colonies (data not shown). At the same time a very
small number of colonies lost pRS315 plasmid with wild-
type SUP45. (Table 1, first column). These data are con-
sistent with the result of plasmid shuffle on 5-FOA (Fig.
4A and 4D): again the least frequency of wild-type plas-
mid loss (0.3%) was obtained for sup45-105 and the high-
est (6.3%) for sup45-101.
Ura+ Leu- colonies were selected and tested for adenine
and tryptophan auxotrophy. In all cases sup45-n muta-
tions led to suppression of ade1-14 and trp1-289 (Figure
4B). Cells bearing pRS316/sup45-n plasmid were re-trans-
formed with pRS315-SUP45 plasmid and the experiment
repeated (Table 1, second column). The results show that
after growth in the presence of mutant alleles of SUP45
the ability to lose the plasmid with the wild-type allele of
SUP45 increased. To determine whether such an increase
could be explained by reversions of sup45-n  alleles to
wild-type allele during shuffle experiments in yeast, the
corresponding plasmids were prepared from yeast trans-
formants and sequenced. In all tested cases the presence of
sup45-n mutation was confirmed (data not shown).
Do nonsense mutations in the SUP45 gene lead to 
lethality in meiosis?
Previously it has been shown that sup45  nonsense
mutants, selected in the presence of SUQ5, are not viable
in the absence of the SUQ5 tRNA suppressor [29]. In our
work such mutants are viable for three distinct yeastBMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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strains all of which do not contain SUQ5. Thus the main
difference between our data and previously published
data [29] may be explained by different approaches to
selection the mutants used. In addition, in our work, plas-
mid shuffle analysis was used to test the viability of sup45-
n mutants as analysis of meiotic products has been used
to characterize the viability of sup45-0 (0 because of ochre)
mutants [29].
To compare our results to the ones of Stansfield et al. [29]
we transformed diploid strain D1628 (a parent strain for
1A-D1628 strain used in plasmid shuffle experiment) het-
erozygous for SUP45 disruption with plasmids carrying
sup45-n  alleles and performed tetrad analysis. Table 2
shows that no His+ Ura+ segregants were obtained in the
case of the sup45-105 allele (where His+ is the marker for
the SUP45 gene disruption and Ura+ – for the plasmid
presence). This result cannot be explained by the loss of
the corresponding plasmid since the stability of plasmids
in all tested diploids were practically the same (Table 2).
For all other sup45-n alleles the appearance of His+ Ura+
segregants has been registered, although their amount was
less than in the case of plasmids with wild-type SUP45.
The presence of sup45-n alleles in His+Ura+ spore clones
was confirmed by suppression of ade1-14 and trp1-289
alleles (data not shown). The same results were obtained
using another diploid strain Y23282, the derivative of
S288C (data not shown).
Microscopic examination of the lethal spores from the
control strain showed that all were unable to carry out
mitotic divisions and stayed at the one cell stage. This
result could be explained by loss of SUP45 bearing plas-
mids. In contrast, in the case of diploids bearing mutant
sup45-n alleles most lethal spores form microcolonies of 4
to 20 cells (Table 3), many of which were abnormally
Nonsense mutations in the SUP45 gene lead to thermosensi- tivity Figure 3
Nonsense mutations in the SUP45 gene lead to ther-
mosensitivity. Thermosensitivity of strains bearing sup45-n 
mutations. The same strains as in (2A) were tested on the 
rich medium (YPD) at 37°C.
Nonsense mutations in the SUP45 gene confer the viability in  the different genetic backgrounds Figure 4
Nonsense mutations in the SUP45 gene confer the 
viability in the different genetic backgrounds. A. 
Strain 1A-D1628 bearing SUP45 disruption was co-trans-
formed by pRS316/SUP45 and pRS315/sup45-n plasmids. The 
cotransformants bearing pRS316/SUP45 and vector pRS315 
only were used as a negative control. The transformants 
were assayed for growth by plating on 5-FOA medium to 
select against the URA3 plasmid pRS316/SUP45 carrying a 
wild-type copy of SUP45. Ten serial dilutions of yeast suspen-
sions of the same density were used. Five independent trans-
formants for each combination were tested. Representative 
results are shown. B. Plate assays showing the growth of 
transformants of 1A-D1628 bearing pRS316/SUP45 or 
pRS316/sup45-n plasmids on the synthetic medium without 
adenine (SC-Ade) or tryptophan (SC-Trp) at 25°C. The 
strains were tested in the same way as in Fig. 2A. C. West-
ern blot showing the expression of full-length eRF1 (49 kDa) 
and truncated eRF1 proteins in the same strains as in (B). D. 
Complementation of the SUP45 gene disruption in the strain 
13A-Y23282 by sup45-n mutations. The transformants with 
vector pRS315 were used as a negative control. The same 
plasmids as in (A) were used.BMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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shaped buds or abnormally elongated. Apparently, the
SUP45::HIS3 [sup45-n] spores can germinate but the cells
fail to divide after a few cell cycles.
To determine whether the presence of SUQ5 mutation
could increase the viability of sup45-n segregants, the dip-
loid strain heterozygous for both the SUQ5 and sup45-n
alleles was sporulated and tetrads were analyzed for cell
viability and suppression (Table 4). As expected, SUQ5
mutation significantly increased the frequency of His+
Ura+ segregants for all sup45-n mutations except sup45-
107. These data are consistent with the known properties
of SUQ5 tRNA to suppress UAA, but not UGA codon [33].
Nonsense mutations in SUP45 are recognized as stop 
codons in the presence of wild-type SUP45 allele
The readthrough of sup45-n mutations could be explained
in several ways such as a decreased level of eRF1 or weak
termination context surrounding sup45-n mutations. To
assess these possibilities we determined whether the
sup45-n alleles could be reassigned in the presence of wild-
type SUP45 allele. For this purpose the two-hybrid system
was used [37]. This approach allows us to distinguish full-
length eRF1 encoded by the SUP45  gene from the
readthrough product encoded by the sup45-n allele. It is
known that the interaction of eRF1 with eRF3 is mediated
by the C-terminus of eRF1 [20,21]. Thus, in the absence of
readthrough, no truncated eRF1 proteins encoded by
sup45-n alleles will interact with eRF3. Accordingly, yeast
eRF3 fused to GAL4DB in vector pGBT9 and eRF1/Sup45
fused to GAL4AD in vector pGADGH were introduced into
strain HF7C separately or together and tested for activa-
tion of HIS3 reporter gene. In the control experiment co-
transformants harboring either of the plasmids and a vec-
tor alone (pGBT9 or pGADGH) did not grow in the
absence of histidine. The co-transformants harboring
both yeast (eRF3/Sup35and eRF1/Sup45) full-length pro-
teins were used as a positive control. Figure 5A shows that
only co-transformants bearing full length eRF1 and eRF3
proteins grew on the selective medium with 3-amino-
1,2,4-triazole (3-AT), while co-transformants carrying
truncated variants of eRF1 did not.
Western blot analysis revealed the presence of fusion pro-
tein as well as wild-type eRF1 protein for all transform-
ants, except sup45-102  (Figure 5B). No readthrough
Table 2: Nonsense mutations in SUP45 lead to decreased ascospore viability
D1628 transformed with 
plasmids:
Plasmid 
stability %
Total number of tetrads Tetrads with indicated number of viable spores % of His+Ura+ segregants a
43 21
pRS316/SUP45 7 1 4 9 71 9 2 21 2 7
pRS316/sup45-101 74 52 6 6 38 2 15
pRS316/sup45-102 71 30 1 1 26 2 5
pRS316/sup45-104 74 48 0 2 42 4 2
pRS316/sup45-105 72 35 0 0 32 3 0
pRS316/sup45-107 69 31 3 5 21 2 14
a The amount of His+Ura+ segregants is a characteristic of sup45-n allele presence (His+ is the marker for the SUP45 gene disruption and Ura+- for 
the pRS316 plasmid presence). The data correspond to the sum of two experiments but the cell number in nonviable colonies was calculated from 
only one (Table 3).
Table 1: The efficiency of maintenance of pRS315/SUP45 plasmid on SUP45::HIS3 [sup45-n] background
Transformants of 1A-D1628 bearing plasmids a:%  o f  U r a + Leu- colonies after rounds of selection:
pRS315 [LEU2] with: pRS316 [URA3] with: I b II c
SUP45 SUP45 9.5 ± 1.1 11.0 ± 0.7
SUP45 sup45-101 6.3 ± 0.8 10.9 ± 1.1
SUP45 sup45-102 2.2 ± 0.7 4.3 ± 0.9
SUP45 sup45-104 2.5 ± 0.9 12.1 ± 2.2
SUP45 sup45-105 0.3 ± 0.2 15.6 ± 1.7
SUP45 sup45-107 2.0 ± 0.3 5.0 ± 0.6
a Strain 1A-D1628 bearing disruption of the SUP45 gene (SUP45::HIS3) and the SUP45 gene on pRS315 plasmid was transformed with pRS316/
sup45-n plasmids. b The frequency of pRS315/SUP45 loss in cotransformants was determined (I). c Transformants bearing only sup45-n plasmids 
were selected on SC- Ura medium, re-transformed with pRS315/SUP45 plasmid and the frequency of pRS315/SUP45 loss in cotransformants was 
determined again (II). At least 3 independent transformants were tested for each plasmid combinations. The average data with standard errors (± 
SE) are presented.BMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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proteins were observed for any of the plasmids bearing
sup45-n mutations except sup45-101, for which a small
amount of readthrough fusion protein was detected. Thus,
in the presence of a normal amount of wild-type eRF1 the
readthrough of sup45-n alleles is completely repressed.
Discussion
In this study we have shown that yeast containing non-
sense mutations in the SUP45 gene can be selected for as
viable strains. The product of this gene, translation termi-
nation factor eRF1, is essential and even small deletions
from its C-terminus (about 30 amino acids) are lethal
[20,21]. Consistent with this, we have shown that the full-
length eRF1 protein is present in all mutants bearing
sup45-n alleles, although in smaller amounts.
There are several processes known that can overcome the
effect of nonsense codons, such as suppression by either
mutated or natural cellular RNA [reviewed in [38]]. The
readthrough of in-frame stop-codon could be also pro-
grammed by weak termination context and/or RNA-sec-
ondary structure elements [see [1] for recent review].
Many of the commonly used E. coli laboratory strains as
well as wild-type populations contain UAG suppressor
tRNAs [39]. For S. cerevisiae such data are unknown. The
existence of a mutated nonsense-suppressed tRNA gene in
the genetic background of the parent strain employed in
our study is unlikely, because of the codon-specificity of
such suppressors: in our work both ochre (UAA) and opal
(UGA) sup45-n mutations have been isolated. Further the
parent strain as well as strains used for testing viability of
sup45-n mutations, do not possess any suppressor activity.
Moreover, no mutations in the tRNA encoding genes were
found in strain S288C [40], the derivative of that used in
our plasmid shuffle experiments.
Viable opal nonsense mutation (supK584) in the essential
gene prfB encoding bacterial release factor RF2 had been
described in S. typhimurium [30]. It has been shown that
this mutation reduces the cellular amount of RF2. Such a
reduction in RF2 level leads to inefficient termination of
translation and thus to autosuppression. Nonsense muta-
tions have been also isolated in the essential SUP35 gene
encoding translation termination factor eRF3, both
(sup35-2 (UAG) and sup35-21 (UAA)) [41,42] being via-
ble. Thus, different translation termination factors, such
as RF2, eRF1 and eRF3, have a common property – the via-
bility of nonsense mutants for their encoding genes. Non-
sense mutations in the SUP45 gene (sup45-0) in SUQ5-
ochre suppressing background have been previously iso-
lated; nevertheless, they could not support viability in the
Table 3: Nonsense mutations in SUP45 lead to the block of cell divisions after spore formation
D1628 transformed with 
plasmids:
Total number of non-viable 
spores
Percentage of non-viable spores forming microcolony with following numbers of cells:
5–20 3 – 4 1
pRS316/SUP45 22 0 0 100
pRS316/sup45-101 68 3 1 96
pRS316/sup45-102 52 15 25 60
pRS316/sup45-104 64 8 28 64
pRS316/sup45-105 39 13 18 69
pRS316/sup45-107 25 24 8 68
Table 4: Nonsense mutations in SUP45 support ascospore viability in presence of SUQ5
Strain D1638 
transformed with 
plasmids:
Total number of 
tetrads
Number of tetrads with viable spores % of His+Ura+ 
segregants
4321
pRS316/SUP45 3 581 2 1 413 2
pRS316/sup45-101 36 11 11 13 1 33
pRS316/sup45-102 3 191 0 1 113 5
pRS316/sup45-104 2 01 71 111 7
pRS316/sup45-105 3 661 0 1 823 0
pRS316/sup45-107 3 62 92 411 8BMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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absence of SUQ5  mutation leading to lethality in the
crosses with wild-type strain [20].
It is well known that the relative efficiency of termination
depends on the local sequence context surrounding the
termination codon [reviewed in [1,2,43]]. In numerous
experiments in E. coli it has been shown that the most
important determinant of termination efficiency is the
nucleotide immediately following the stop codon (the +4
base). This suggests that the translation termination signal
consists of four nucleotides [39,44]. Statistical analysis of
sequences surrounding stop codons at natural termina-
tion sites has also shown a significant bias in the bases
around the stop codon, the most marked of which is the
nucleotide immediately following the stop codon
[reviewed in [39,43]]. This analysis identified contexts
that favor termination in vivo in different organisms,
among which were E. coli and S. cerevisiae. Although this
context is different in bacteria and yeast, there is a quite
good correlation between the frequency of +4 nucleotide
occurrence at natural sites and termination efficiency of
tetranucleotide stop codon [44,45]. For UAA stop codon
the termination efficiency is influenced by the fourth posi-
tion in the order G > A > U ≥ C (from most efficient to
least efficient termination) and the most frequent +4 con-
text in S. cerevisiae is A, while C is less frequent [45]. In
accordance with these data the relative level of eRF1 full-
length protein correlates with the strength of the transla-
tion termination signal (Table 5). No UAAA mutations
were isolated in our screen. For UGA stop codon the trans-
lation efficiency is influenced by the fourth position in the
order G>U>A>C, while for UAG the order is different
(A>U>C>G) [45]. Indeed, sup45-107 (UGAA) mutation,
as well as other sup45-n mutations, is situated in a weak
termination context. Thus, premature stop codons in the
SUP45 gene can be suppressed with relatively high effi-
ciency depending on the surrounding sequence.
Interestingly, all sup45-0 mutations, that led to the appear-
ance of an in-frame UAA stop codon [29], were situated in
the strongest +4 context where purine was presented in
fourth position. However the discrepancy between our
data and that of Stansfield et al. cannot be explained by
different context influence because one viable sup45-n
mutation which is completely identical to sup45-18 [29]
has been isolated (Borchsenius, Zhouravleva, unpub-
lished). Also, the readthrough of premature stop codons
in the SUP45 gene cannot be explained only by weak ter-
mination context because in the presence of wild-type
eRF1 protein there was no readthrough of fusion Gal4-
Sup45-n mRNAs. Interestingly, the possibility of isolating
viable nonsense mutations in the SUP45 gene due to the
existence of wild-type tRNAs in the yeast cytoplasm has
been predicted [29]. Natural nonsense suppression is a
widespread mechanism of translation regulation
[reviewed in [38]]. To date, the ability of different yeast
tRNA to translate all three stops codons has been shown
[46-48]. Experiments are in progress to identify the precise
mechanism leading to readthrough of sup45-n mutations.
Although sup45-n mutations do not lead to lethality in dif-
ferent genetic backgrounds, their viability increased after
growth in the absence of wild-type allele. The mainte-
nance of plasmid containing a wild-type copy of the
SUP45 gene changed: the frequency of its loss was very
low compared with plasmid bearing sup45-n mutation,
however, this frequency significantly increased after
reshuffle of SUP45 bearing plasmid in sup45-n mutants.
In crosses between the sup45-n strains and the wild-type
strain the viability of segregants bearing sup45-n alleles
was higher than in meiotic progeny of diploid cells heter-
ozygous for SUP45 disruption. Possibly, additional muta-
tions were selected during the first stage of selection, or,
alternatively, a decreased level of eRF1 could influence
expression of other components of the translation termi-
Expression of sup45-n mutations in the presence of wild-type  amount of eRF1 protein does not lead to readthrough Figure 5
Expression of sup45-n mutations in the presence of 
wild-type amount of eRF1 protein does not lead to 
readthrough. A. Two-hybrid interactions. Strain HF7C was 
co-transformed with pGADGH plasmids carrying different 
sup45-n mutations and pGBT9/SUP35 plasmid. The interac-
tions were tested by the extent of resistance to 3-AT. Ten 
serial dilutions of yeast suspensions of the same density were 
used. Five independent transformants for each combination 
were tested. Representative results are shown. B. Western 
blot showing the expression of full-length eRF1+Gal4 and 
truncated eRF1+Gal4 proteins with predicted molecular 
mass in the same transformants as at (A).BMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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nation complex. Further studies are necessary to identify
the precise mechanism of this phenomenon.
It is known that high levels of nonsense suppression in
yeast are lethal [49]. Most of sup45-n mutations lead to
decreased spore viability. Spores bearing sup45-n muta-
tions are characterized by limited growth after germina-
tion leading to the formation of micro-colonies of 4 to 20
cells. The arrest of cell division in sup45-n bearing spores
cannot be explained by the presence of some residual
eRF1 protein derived from the heterozygous diploid. It
has been shown that disruption of the SUP45 gene leads
to blockage of the cell cycle at the START of G1, manifested
as the inability of spores to produce microcolonies [50].
Interestingly, the presence of mutated suppressor tRNA
also led to increase spore lethality [51] and to the arrest in
cell division at approximately the 50-cell stage [52]. The
combination of sup45-n  alleles with SUQ5  mutation
restores the viability of sup45-n spores as well as sup45-0
mutations [29].
All sup45-n mutations (but not all missense mutations)
led to thermosensitivity. The data concerning the effi-
ciency of translation termination at different temperatures
are controversial: for S. typhimurium it was higher at 42°C
than at 37°C in both supK584 and wild-type strains [30].
However for S. cerevisiae the efficiency of termination did
not change in wild-type strain, but was lower at 33°C than
at 30°C in the sup45 mutant [33]. We did not find a sig-
nificant difference in the amount of full-length eRF1 pro-
tein at the non-permissive temperature as compared with
the permissive temperature both in the mutant sup45-104
strain and in the wild-type strain. Thus thermosensitivity
of sup45-n mutants cannot be explained by the further
reduction in the amount of eRF1 protein produced in the
mutant at high temperature as proposed for RF2 protein
in supK584 strain [30].
The sup45-n mutations lead to a high level of nonsense
codon suppression (up to 42% for UGA stop codon when
measured in the β-galactosidase assay) because of
decreased level of eRF1. This result is consistent with pre-
vious findings [29,53]. However, additional causes can-
not be excluded as the full-length eRF1 protein produced
in sup45-n mutants contains missense substitutions at the
amino acid positions corresponding to the premature
stop codons. Indeed, most of sup45-n mutations are situ-
ated in highly conserved regions of eRF1 (data not
shown).
Previously it has been shown that truncated eRF1 proteins
of 411, 360 and 359 amino acids were still able to bind to
the ribosome [29]. In our experiments truncated eRF1
proteins of 384, 316 and 282 amino acids, but not of 265
amino acids, bind to ribosome. This result suggests that
the eRF1 ribosome-binding site is localized between
amino acids 265 and 282. Consistent with these data, it
has been previously proposed that for human eRF1 a
ribosome-binding site includes amino acids 246 to 270
[24].
The eRF3-binding site on S. cerevisiae eRF1 is located in
the C-terminal region, in particular the deletion from
eRF1 of the 19 C-terminal amino acids abolish its interac-
tion with eRF3 [20,21]. The two-hybrid analysis used in
our work confirms that loss of the extreme C-terminus of
eRF1 abolishes its interaction with eRF3.
The studies described above raise a question about mech-
anisms leading to viability of nonsense mutations in
essential genes. To date such mutations have been isolated
in the several essential genes of S. cerevisiae [41,42,54,55]
and the existence of different mechanisms has been pro-
posed. Viability of pol3  nonsense mutations has been
explained by the presence of [PSI+] factor encoded by the
SUP35  gene in the parent strain, which leads to
readthrough of stop codons in the mutated POL3 gene
[55]. Analysis of snm1 nonsense mutations revealed that
these mutations are suppressed by amplification of the
plasmid carrying snm1  alleles. Plasmid amplification
leads to an increase in SNM1  mRNA level, which, is
believed could led to a partial readthrough resulting in the
appearance of full length Snm1 protein. Interestingly,
snm1 mutations do not result in translation infidelity sug-
gesting that translation suppression was specific for the
SNM1 gene [54]. The viability of sup35-2 and sup35-21
mutations was explained by reduction of eRF3 level that
causes inefficient termination of translation and leads to
autosuppression [41,42]. However, the precise mecha-
nism leading to readthrough of these mutations, as well as
Table 5: The efficiency of UAA-readthrough of sup45-n mutations depends on the base following stop codon
SUP45 allele Termination tetranucleotide Level of eRF1 (% from wild type) Natural occurrence in highly expressed genes (%) [45]
sup45-102 UAAG 8 35.9
sup45-104 UAAU 13 16.7
sup45-105 UAAU 14 16.7
sup45-101 UAAC 32 1.3BMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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sup45-n mutations, remains unclear. Future studies will
include the identification of components that can partici-
pate in this process.
Conclusions
The data presented in this work show that nonsense muta-
tions (sup45-n) in the SUP45 gene can be isolated and that
such mutations support viability in different genetic back-
grounds. All these mutations lead to a decreased level of
full-length eRF1 protein and thus to the ability to suppress
other nonsense mutations. It could appear that a very low
level of eRF1 (up to 10% relative to wild type) is sufficient
to support viability. All sup45-n mutations are situated in
weak +4 termination context and the relative level of eRF1
full-length protein correlates with the strength of the four
nucleotide translation termination signal. Most of sup45-
n mutations lead to decreased spore viability and thermo-
sensitivity. Our data confirm that the site of interaction
with eRF3 is localized in the C-terminus of eRF1. Our
results suggest that the ribosome-binding site of yeast
eRF1 is localized between amino acids 265 and 282.
Methods
Strains, media and reagents
The Saccharomyces cerevisiae strains used in this study are
listed in additional file 1. All strains were [psi-]. Strains
BSC483/4c and D1628 have been described earlier
[56,57]. Yeast cultures were grown in standard rich (YPD)
or synthetic (SC) media [58] at 25°C. Usually, omnipo-
tent SUP45 mutations are selected by reversions of two
nonsense mutations of different types (for example, UAA
and UGA) [see [59] for review], this decreases the proba-
bility of obtaining mutations in tRNA genes. In this work
we used reversions of two nonsense mutations of the
same type (UAA). The yeast strain 1B-D1606 containing
nonsense mutations of all types have been constructed.
For selection of suppressor mutants, simultaneous spon-
taneous reversions to histidine and lysine prototrophy
were employed. His+ Lys+ revertants were crossed with
strains bearing sup35  or  sup45  mutations to identify
SUP45 mutants. Standard methods of yeast genetics were
used [58]. Transformants were grown in the media selec-
tive for plasmid maintenance (SC-Trp, SC-Leu, SC-Ura).
Suppression of nonsense mutations was estimated by
growth at 25°C on synthetic media lacking the corre-
sponding amino acids. To determine the frequency of
plasmid loss transformants were plated at 200 cells per
Petri dish on YPD medium, grown at 25°C for several
days and replica plated on SC-Ura or SC-Leu media.
About 200 to 500 colonies from 3 independent trans-
formants, were tested. For plasmid shuffle, selective
medium containing 1 mg/ml 5-fluoroorotic acid (5-FOA,
Sigma) was used. Yeast transformations were performed
as described previously [60]. 3-AT plates contained differ-
ent concentrations of 3-amino-1,2,4-triazole (Sigma). The
two-hybrid interactions were assessed by the ability to
transactivate HIS3 reporter gene (to confer growth in the
absence of histidine and in the presence of different con-
centrations of 3-AT).
Bacterial strains used in the work were JM109 (recA1
supE44 endA1 hsdR17 gyrA96 relA1 thi Δ (lac-proAB) F'
[traD36 proAB+lacIqlacZΔM15]) [61] and XL1-Blue (recA1,
endA1, gyrA96, thi-1, hsdR17, supE44, relA1 [F', proAB, lacIq,
Δ(lacZ)M15, Tn10(tet)]) [62].
For quantitative characterization of nonsense suppression
in sup45 mutants β-galactosidase reporter system [33] was
used. Mutants were transformed with pUKC815 plasmid
containing PGK1-lacZ fusion (control) or with pUKC817,
818, 819 plasmids carrying TAA, TAG, TGA (termination
codons), respectively, cloned in frame with lacZ. β-galac-
tosidase activity was determined as described [63]. Only
in the case of nonsense suppression could active β-galac-
tosidase be synthesized. Efficiencies of suppression were
calculated as a ratio of β-galactosidase activity in cells har-
boring lacZ with premature termination codon to that in
cells with a normal allele of lacZ. Values for liquid β-galac-
tosidase assay represent the mean of at least three assays
from each of three independent transformants.
DNA/RNA methods
Plasmid DNA was isolated as described [62]. Yeast
genomic DNA was prepared using a lyticase (Sigma) and
genomic DNA purification kit (Promega).
The SUP45 ORF was amplified by PCR from the genomic
DNA of yeast strains using oligonucleotides correspond-
ing to the 5' of the ORF (82 – CATTTCGGCTTGTCTCC or
99 – TTTGTGATTCCATGAAGAGGATAACAGA CT) and
an oligonucleotide, complementary to the 3' end of the
ORF (83 – TCTGGCATCTAGTGATTAAATTC). PCR reac-
tions were performed using Taq or Pfu polymerase
(Promega) as recommended by the manufacturer.
Sequences of PCR primers used for double strand
sequencing were: 82, 83 (see above), 45 – CGACTGCAC-
CTAAATCCAATG, 87 – CCTCATTATCCTCGGCATC, 92 –
GTTCGATGTCAAAAGTGAC, 93 – GACGAAATTTC-
CCAGGACAC, 94 – CAAAAACTTCGGTGCTAC, 100 –
GACATCGAACCTTACAAACCTATC, 101 – ctgctatcacttc-
cacccaac, 104 – GAAAGGTCGCCGAAGTTGCTG, 105 –
CAGCAACTTCGGCGACCTTTC. At least two independent
PCR-products were sequenced and subcloned in pGEM-T
vector (Promega). The presence of a mutated allele in
pGEM-T plasmid was verified by sequencing.
Plasmids
Plasmid pRS316/ySUP45 was constructed by subcloning
the XbaI-HindIII fragment from pYex-SUP45 (a gift of V.
Kushnirov) in the same sites of pRS316 [64]. PlasmidBMC Molecular Biology 2003, 4:2 http://www.biomedcentral.com/1471-2199/4/2
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pRS315/SUP45  was described earlier [57]. Plasmids
pRS316/sup45-101, pRS316/sup45-102, pRS316/sup45-
104, pRS316/sup45-107 were obtained by substitution of
the BglII-EcoRI fragment of pRS316/SUP45  for BglII-
EcoRI fragments from pGEM-T/sup45-101, pGEM-T/
sup45-102, pGEM-T/sup45-104  and pGEM-T/sup45-107,
respectively. Plasmid pRS316/sup45-105 was obtained by
substituting the BglII-BamHI fragment of pRS316/SUP45
for BglII-BamHI fragment from pGEM-T/sup45-105. Plas-
mids pRS315/sup45-101, pRS315/sup45-102, pRS315/
sup45-104, pRS315/sup45-105, and pRS315/sup45-107
were obtained by substituting BglII-BamHI fragment of
pRS315/SUP45 for BglII-BamHI fragments from pRS316/
sup45-101, pRS316/sup45-102, pRS316/sup45-104,
pRS316/sup45-105 and pRS316/sup45-107, respectively.
Plasmids pGBT9/SUP35  and pGADGH/SUP45  were
described previously [41]. Plasmids pGADGH/sup45-101,
pGADGH/sup45-102, pGADGH/sup45-104  and
pGADGH/sup45-107 were obtained by substituting BglII-
EcoRI fragment of pGADGH/SUP45 for BglII-EcoRI frag-
ment from pGEM-T/sup45-101, pGEM-T/sup45-102,
pGEM-T/sup45-104 and pGEM-T/sup45-107, respectively.
Plasmid pGADGH/sup45-105 was obtained by substitut-
ing BglII-BamHI fragment of pGADGH/SUP45 for BglII-
BamHI fragment from pGEM-T/sup45-105.
Protein procedures
Yeast cultures were grown in YPD medium or in a
medium selective for plasmid markers. Ribosomal frac-
tions were prepared as described [65]. From ten to twenty
μg of the proteins were separated on 12 % SDS-polyacry-
lamide gel according to Laemmli [66], and transferred to
a nitrocellulose membrane (Immobilon-P). Western blot
analysis was performed with 1/100 diluted polyclonal
rabbit antibodies that were obtained against mixture of
peptides from the N-terminal (CLTDEYGTASNIKSRV)
and the C-terminal (VDESEDEYYDEDEGS) regions of S.
cerevisiae eRF1 and then purified against the N-terminal
peptide of eRF1. Bound antibodies were detected using
the Amersham ECF system (Amersham Pharmacia Bio-
tech) and the Storm 840 PhosphorImager (Molecular
Dynamics, USA). Signal intensities were quantified using
ImageQuaNT 5.2 software (Molecular Dynamics, USA).
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